SCHEMBL29856293

SCHEMBL29856293

Cc1cccc2nc3c(O)cc(Cl)cc3nc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 5/20 0.50
ACHE P22303 1/20 0.48
GAA P10253 5/20 0.44
MAPT P10636 3/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 2/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPK1 P28482 1/20 0.38
DHODH Q02127 1/20 0.37
POLB P06746 2/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
G6PD P11413 1/20 0.37
PKM P14618 1/20 0.37
MYC P01106 1/20 0.37
MAX P61244 1/20 0.37
MGAM O43451 3/20 0.36
SI P14410 3/20 0.36
MGAM2 Q2M2H8 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29856269 1.00 NQO2 (0.50) NQO2ACHEGAAMAPTRAB9A
SCHEMBL29856223 0.81 MAPT (0.57) NQO2ACHEGAAMAPTRAB9A
SCHEMBL13271195 0.81 ACHE (0.75) NQO2ACHEGAAMAPTRAB9A
SCHEMBL29856307 0.81 MAPT (0.51) NQO2ACHEGAAMAPTRAB9A
SCHEMBL29856225 0.81 NQO2 (0.50) NQO2ACHEGAAMAPTRAB9A
SCHEMBL29856420 0.78 NQO2 (0.56) NQO2GAAMAPTRAB9AALDH1A1
SCHEMBL26020985 0.78 NQO2 (0.53) NQO2ACHEGAAMAPTRAB9A
SCHEMBL31643056 0.76 RAB9A (0.53) NQO2ACHEGAAMAPTRAB9A
SCHEMBL20475325 0.76 RAB9A (0.53) NQO2ACHEGAAMAPTRAB9A
SCHEMBL13271231 0.75 ACHE (0.65) NQO2ACHEGAAMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12060334-B2 3-substituted phenazine derivatives as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2024-08-13 US disclosed
US-20220289689-A1 3-SUBSTITUTED PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 2022-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220289689-A1 3-SUBSTITUTED PHENAZINE DERIVATIVES AS ANTIMICROBIAL AGENTS ROS1, NOX4, NOX5 NQO2 139/4885ACHE 1515/4885GAA 2614/4885
US-12060334-B2 3-substituted phenazine derivatives as antimicrobial agents ROS1, NOX4, NOX5 NQO2 139/4885ACHE 1515/4885GAA 2614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.